Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Apr 24, 2024

SELL
$0.13 - $76.84 $338 - $199,784
-2,600 Closed
0 $0
Q2 2022

Apr 24, 2024

SELL
$72.62 - $79.98 $14,524 - $15,996
-200 Reduced 7.14%
2,600 $202 Million
Q1 2022

Apr 24, 2024

BUY
$61.48 - $73.72 $172,144 - $206,416
2,800 New
2,800 $206 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Bulltick Wealth Management, LLC Portfolio

Follow Bulltick Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bulltick Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bulltick Wealth Management, LLC with notifications on news.